Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cardiovascular disease preventing

Recently, another plausible mechanistic basis for isoflavone-mediated cardiovascular disease prevention has been proposed. In a study to find the... [Pg.199]

Mosca L, Appel LJ, Benjamin EJ et al. (2004) Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 109 672-693... [Pg.356]

The STOP-NIDDM trial demonstrated that -glucosidase therapy in prediabetic persons successfully prevented a significant number of new cases of type 2 diabetes and helped restore beta-cell function, in addition to reducing cardiovascular disease and hypertension. Intervention with acarbose also reduced cardiovascular events in persons with diabetes. Diabetes and cardiovascular disease prevention may become a further indication for this class of medications. [Pg.945]

Kohlmeier, L. and Hastings, S.B. 1995. Epidemiologic evidence of a role of carotenoids in cardiovascular disease prevention. Am. J. Clin. Nutr. 62(Suppl. 6), S1370-S1376. [Pg.157]

Morgan SL, et al. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm,low dose methotrexate therapy for rheumatoid arthritis implications for cardiovascular disease prevention. J Rheumatol 1998 25(3) 44l-446. [Pg.182]

De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, et al. European guidelines on cardiovascular disease prevention in clinical practice. Ear. Heart J., 2003, 24, 1601-1610. [Pg.155]

D. A. Morrow and P. M. Ridker High sensitivity c-reactive protein (hs-CRP) a novel risk marker in cardiovascular disease. Preventive Cardiology 1, 13 (1999). [Pg.955]

Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States Findings of the National Conference on Cardiovascular Disease Prevention. Circulation 2000 102 3137-3147. [Pg.425]

Postmenopausal hormone treatment with oral combined estrogen plus progestogen has no benefit for cardiovascular disease prevention and increases the risk of breast cancer, coronary heart disease events, stroke, and venous thromboembolic events. However, it reduced the rates of hip fracture and colorectal cancer. [Pg.1493]

Bioavailability studies are essential if we are to understand the possible role of plant phenolics in cardiovascular disease prevention. Recent studies showing that food flavonoids can be absorbed as glycosides, which goes against conventional knowledge concerning flavonoid absorption, indicate the need for such bioavailability studies. [Pg.789]

Guttenplan N, Lee C, Frishman WH. Inhibition of myocardial apoptosis as a therapeutic target in cardiovascular disease prevention focus on caspase inhibition. Heart Dis. 2001 3 313-318. [Pg.180]

Ginter, E., Cardiovascular disease prevention in eastern Europe, Nutrition, 14, 452-457,1998. [Pg.64]

Mendis, S., Puska, R, Norrving, B., 2011. Global Atlas on Cardiovascular Disease Prevention and Control. World Health Organization in Collaboration with the World Heart Federation and the World Stroke Organization, Geneva. [Pg.413]

Vitamins and Folate Fortification in the Context of Cardiovascular Disease Prevention... [Pg.67]

Table 3.1 Folic acid, Bg, B12 and cardiovascular outcomes. This table summarizes all the important double-blind randomized clinical trials with the use of folie acid, Bg and B12 vitamins for cardiovascular disease prevention. 5-MTHF 5-methyl tetrahydrofolate CKD chronic kidney disease CVD cardiovascular disease DVT deep vein thrombosis ESRD end stage renal disease FA folic acid f/u follow-up MI myocardial infarction RR relative risk UA unstable angina. Table 3.1 Folic acid, Bg, B12 and cardiovascular outcomes. This table summarizes all the important double-blind randomized clinical trials with the use of folie acid, Bg and B12 vitamins for cardiovascular disease prevention. 5-MTHF 5-methyl tetrahydrofolate CKD chronic kidney disease CVD cardiovascular disease DVT deep vein thrombosis ESRD end stage renal disease FA folic acid f/u follow-up MI myocardial infarction RR relative risk UA unstable angina.
Olsson, A.G., 2010b. HDL and LDL as therapeutic targets for cardiovascular disease prevention the possible role of niacin. Nutrition, Metabolism Cardiovascular Disease. 20 553-557. [Pg.687]

Mendis S, PuskaP, Norrving B (2011) Global atlas on cardiovascular disease prevention and control. World Health Organization, Geneva... [Pg.3687]

Klendler BS (1987) Garlic (Allium sativum) and onion (Allium cepa) a review of their relationship to cardiovascular disease. Prevent Med 16 670-685... [Pg.286]

Chapman, M. J. (2005). Beyond the statins new therapeutic perspectives in cardiovascular disease prevention. Cardiovasc. Drugs Ther., 19,135-139. [Pg.213]

See other pages where Cardiovascular disease preventing is mentioned: [Pg.207]    [Pg.243]    [Pg.444]    [Pg.1]    [Pg.24]    [Pg.660]    [Pg.458]    [Pg.447]    [Pg.175]    [Pg.788]    [Pg.8]    [Pg.212]    [Pg.113]    [Pg.7]    [Pg.74]    [Pg.630]    [Pg.74]    [Pg.1812]    [Pg.721]   
See also in sourсe #XX -- [ Pg.370 ]



SEARCH



Cardiovascular disease

Cardiovascular disease Prevention Study)

Cardiovascular disease prevention

Cardiovascular disease prevention

Carotenoids cardiovascular disease prevention

Disease prevention

Plant-based diets and prevention of cardiovascular disease

Preventing Diseases

© 2024 chempedia.info